Avandia Panel Rife with Conflict

Avandia Panel Rife with Conflict

The news of Avandia panelist Dr. Abraham Thomas confessing a potential conflict comes after another panelist Dr. David Capuzzi was discovered to be a paid speaker for GSK, the drug…

More in Health >
FDA Panel recommends keeping Avandia on the market

FDA Panel recommends keeping Avandia on the market

In a split decision vote 20 to 12, an FDA panel has decided to leave diabetes drug Avandia on the market despite recent studies suggesting that Avandia can increase heart…

More in Health >
Avandia panel says diabetes drug should stay on market

Avandia panel says diabetes drug should stay on market

Shocker from the FDA advisory panel: it voted Avandia should stay on the market despite the fact it increases the risk for heart attack. Total vote count: 20 for continued…

More in News >
Avandia studies place medication on edge of recall

Avandia studies place medication on edge of recall

Heart Risk from Popular Diabetes Medication The diabetes medication Avandia by GlaxoSmithKline has been the subject of two studies that were released Monday. These studies show that the use of…

More in Health >